礼来公司的口服GLP-1受体激动剂Foundayo(奥格列酮)在三项关键的Type 2 diabetes试验中均展现出更优的糖化血红蛋白A1C控制和体重减轻效果。
印第安纳波利斯,2026年6月8日/PRNewswire/ -- Zepbound(替拉帕肽)的生产商礼来公司(纽约证券交易所代码:LLY)今日公布了ACHIEVE项目中三项3期临床试验的详细结果,这些试验旨在评估小分子药物Foundayo(奥福格列隆)……
该文章暂未提取到完整正文,已从资讯列表和商品关联资讯中自动隐藏。你可以返回文章列表继续浏览其他内容。
Produits lies a cet article
Ces produits ont ete automatiquement associes au titre, au resume et au contenu de l article.
Questions frequentes
Which products are related to this article?
The system matched these relevant products from the article content: Rybelsus sémaglutide (comprimés de sémaglutide) 7 mg, 100 comprimés (version japonaise) – Acheter en ligne Lucius Ceritinib – Acheter en ligne Lucius Trelagliptine – Acheter en ligne Lucius Aprocitentan – Acheter en ligne.
How can I view the medicines discussed in this article?
Use the related product cards below the article to review available specifications, prices, product information, and reviews.
Does this article replace advice from a doctor or pharmacist?
No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.